34 clinical trials matched your search for Solid Tumors. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Solid Tumors Study of Drug Alone and In Combination with Nivolumab in Advanced Solid Tumors Richard Carvajal, MD
Solid Tumors Feasibility, Safety, and Activity Study of BPX-601 in Subjects With Previously Treated Advanced Solid Tumors Mark Stein, MD
Solid Tumors A Study of XmAb23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) Mark Stein, MD
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab Luca Szalontay, MD
Cancer A Study for Patients with Advanced Solid Tumors Using Study Drug BMS-986207 Shaheer Khan, DO
Cancer Study of IDE196 in Patients with Solid Tumors Richard Carvajal, MD
Cancer Study of LN-145 in the Treatment of Squamous Cell Carcinoma of the Head & Neck or Non Small Cell Lung Cancer (NSCLC) Richard Carvajal, MD
Cancer Study of A Vaccine Targeting Shared Neoantigens in Subjects with Advanced Solid Tumors Brian Henick, MD
Cancer Study of BA3011 in Subjects with Advanced Solid Tumors Matthew Ingham, MD
Cancer Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors Luca Szalontay, MD
Cancer Study of AMG510 in Subjects with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer TCR-engineered T Cells in Solid Tumors (ACTengine) Ran Reshef, MD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Richard Carvajal, MD
Cancer Study of ST101 in Patients with Advanced Solid Tumors Fabio Iwamoto, MD
Cancer A Study of ASP9801 in Patients With Advanced Metastatic Solid Tumors Matthew Ingham, MD
Cancer A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors Richard Carvajal, MD
Cancer COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors Benjamin Izar, MD
Cancer A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors Ryan Moy, MD
Cancer LYT-200 Alone and in Combination With Chemotherapy or Anti-PD-1 in Patients With Metastatic Solid Tumors Gulam Manji, MD, PhD
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer Mark Stein, MD
Cancer Study of MPT-0118 Alone or in Combination with Keytruda in Patients with Advanced or Metastatic Cancer Shaheer Khan, DO
Cancer Study of INCB106385 Alone or in Combination with INCMGA00012 in Patients with Advanced Cancer Mark Stein, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of RP-6306 in Combination with Gemcitabine (Chemotherapy) for Patients with Advanced Solid Tumors Ryan Moy, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Richard Carvajal, MD
Cancer Study of RP-6306 in Combination with FOLFIRI in Patients with Advanced Solid Tumors (Colon, Esophageal, or GI Cancer) Ryan Moy, MD
Cancer Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors Benjamin Izar, MD
Cancer Study of SHR-A1904 in Patients with Advanced Solid Tumors Ryan Moy, MD
Cancer Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer Brian Henick, MD
Cancer Study of RMC-6291 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Breast Cancer Study of RLY-2608 in Patients with Breast Cancer Julia McGuinness, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD